These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2516859)

  • 1. Class I MHC molecules and doxorubicin resistant P388 murine leukemic cells.
    DiCicco LM; Lazarus H; Krishan A
    Immunopharmacol Immunotoxicol; 1989; 11(4):583-92. PubMed ID: 2516859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
    Ramachandran C; You W; Krishan A
    Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
    Green WR; Phillips JD
    J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological analysis of H-2 antigens expression on the cell surface of drug- and lectin-resistant mouse tumor cells.
    Opolski A; Duś D; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(1):21-34. PubMed ID: 3778114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
    Ling YH; Priebe W; Perez-Soler R
    Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K; Deshpande SS; Chitnis MP
    Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Rouse W; Riegler F
    Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S; Singh SV; Samy TS; Krishan A
    Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS
    J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.